Cargando…
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide. Several lines of evidence have indicated a pathogenic role of insulin resistance, and a strong association with type 2 diabetes (T2MD) and metabolic syndrome. Importantly, NAFLD appears to enhance the risk for T2M...
Autores principales: | Fruci, Barbara, Giuliano, Stefania, Mazza, Angela, Malaguarnera, Roberta, Belfiore, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856099/ https://www.ncbi.nlm.nih.gov/pubmed/24264040 http://dx.doi.org/10.3390/ijms141122933 |
Ejemplares similares
-
The Role of Metformin in the Management of NAFLD
por: Mazza, Angela, et al.
Publicado: (2012) -
The Insulin Receptor: A New Target for Cancer Therapy
por: Malaguarnera, Roberta, et al.
Publicado: (2011) -
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017) -
The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
por: Malaguarnera, Roberta, et al.
Publicado: (2014) -
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
por: Malaguarnera, Roberta, et al.
Publicado: (2012)